ATE125268T1 - Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes. - Google Patents

Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.

Info

Publication number
ATE125268T1
ATE125268T1 AT89907392T AT89907392T ATE125268T1 AT E125268 T1 ATE125268 T1 AT E125268T1 AT 89907392 T AT89907392 T AT 89907392T AT 89907392 T AT89907392 T AT 89907392T AT E125268 T1 ATE125268 T1 AT E125268T1
Authority
AT
Austria
Prior art keywords
acid
binding protein
protein
insulin
protein complex
Prior art date
Application number
AT89907392T
Other languages
English (en)
Inventor
Robert Charles Baxter
Original Assignee
Cent Sydney Area Health Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cent Sydney Area Health Serv filed Critical Cent Sydney Area Health Serv
Application granted granted Critical
Publication of ATE125268T1 publication Critical patent/ATE125268T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT89907392T 1988-07-15 1989-07-14 Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes. ATE125268T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI931488 1988-07-15
AUPJ335089 1989-03-23

Publications (1)

Publication Number Publication Date
ATE125268T1 true ATE125268T1 (de) 1995-08-15

Family

ID=25643507

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89907392T ATE125268T1 (de) 1988-07-15 1989-07-14 Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.

Country Status (8)

Country Link
US (1) US5936064A (de)
EP (1) EP0424416B1 (de)
JP (4) JP3178714B2 (de)
AT (1) ATE125268T1 (de)
CA (1) CA1341598C (de)
DE (1) DE68923556T2 (de)
HK (1) HK206196A (de)
WO (1) WO1990000569A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133087T2 (de) * 1990-05-30 2003-04-03 Inst Molecular Biology Inc Kombination aus IGF-I und TGF-beta zur Knochenregenerierung
WO1992003152A1 (en) * 1990-08-28 1992-03-05 Chiron Corporation New insulin-like growth factor binding protein (igfbp-4)
US5212074A (en) * 1990-08-28 1993-05-18 Chiron Corporation Genetic material encoding new insulin-like growth factor binding protein igfbp-6
US6326154B1 (en) 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
ATE247164T1 (de) * 1991-01-08 2003-08-15 Chiron Corp Insulinartigen wachstumsfaktor bindendes protein
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
FI94181C (fi) 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
CA2148685A1 (en) 1992-11-04 1994-05-11 Dennis L. Andress Truncated insulin-like growth factor binding proteins having mitogenic activity
JPH09500088A (ja) * 1993-01-29 1997-01-07 アムジェン ボールダー インコーポレイテッド 創傷治癒用組成物
US5747280A (en) * 1995-06-05 1998-05-05 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US5994302A (en) * 1994-12-09 1999-11-30 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
CN1198837C (zh) * 1996-03-20 2005-04-27 戴克斯公司 组织纤溶酶原激活物(tPA)的纯化
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
AUPR030900A0 (en) 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
WO2002026826A2 (en) * 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
US6875570B2 (en) 2000-09-27 2005-04-05 Curagen Corporation Proteins and nucleic acids encoding same
US7153691B2 (en) * 2002-11-13 2006-12-26 G6 Science Corp. Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
US20100143442A1 (en) 2003-02-05 2010-06-10 Queensland University Of Technology Growth factor complexes and modulation of cell migration and growth
WO2011063477A1 (en) 2009-11-30 2011-06-03 Queensland University Of Technology Fibronectin: growth factor chimeras
AU2003903896A0 (en) 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
EP1670822A2 (de) 2003-10-03 2006-06-21 Genentech, Inc. Igf-bindende proteine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE90690T1 (de) * 1987-04-06 1993-07-15 Celtrix Pharma Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.
DK131988A (da) * 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
WO1989009792A1 (en) * 1988-04-12 1989-10-19 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5258257A (en) * 1991-09-23 1993-11-02 Shipley Company Inc. Radiation sensitive compositions comprising polymer having acid labile groups

Also Published As

Publication number Publication date
US5936064A (en) 1999-08-10
WO1990000569A1 (en) 1990-01-25
JP2001252087A (ja) 2001-09-18
JPH03506030A (ja) 1991-12-26
HK206196A (en) 1996-11-22
JP2003319791A (ja) 2003-11-11
EP0424416A1 (de) 1991-05-02
JP2005118052A (ja) 2005-05-12
CA1341598C (en) 2009-09-29
DE68923556D1 (de) 1995-08-24
JP3178714B2 (ja) 2001-06-25
EP0424416A4 (en) 1992-03-18
EP0424416B1 (de) 1995-07-19
DE68923556T2 (de) 1996-04-11

Similar Documents

Publication Publication Date Title
ATE125268T1 (de) Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.
DE3851153D1 (de) Genetische modifizierung von endothelialen zellen.
DK0423980T3 (da) Stamcellefaktor
ES2009590A6 (es) Metodo de preparacion de proteina de cadena pesada del factor tisular humano.
LU91237I2 (fr) Palifermin et ses dérivés pharmaceutiquement acceptables (kepivance)
IL154797A0 (en) Vascular endothelial cell growth factor that is unaccompanied by associated native glycosylation, pharmaceutical composition containing it and use thereof in the manufacture of a medicament for treating trauma affecting the vascular endothelium
ES2094159T3 (es) Produccion de factor de crecimiento de celulas endoteliales vasculares.
EP0434713A4 (en) Hiv-1 envelope muteins lacking hypervariable domains
NO955189L (no) En forkortet keratinocyt vekstfaktor (KGF) med ökende biologisk aktivitet
ATE76878T1 (de) Solubilisierung von protein-aggregaten.
ATE423788T1 (de) Neues tgf-beta-ahnliches cytokin
EP0216742A3 (de) Wachstumsfaktoren
DE3650135T2 (de) Proteingewinnung.
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
FR2662698B1 (de)
DE69330352T2 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
DE69102651T2 (de) Proteaseresistenter pdgf und dessen verwendungen.
EP0336779A3 (de) Durch kovalenten Ersatz von Wasserstoffbrücken stabilisierte Polypeptide
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
ES8600518A1 (es) Metodo in vitro para detectar un estado maligno en un paciente humano.
GB9401689D0 (en) Diagnosis and treatment of endocarditis
KR910007963A (ko) pST의 일부분에 대응하는 아미노산 서열을 갖는 펩티드, 그에 대한 항체 및 pST 활성에 효력을 더하는 방법
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
UA27048C2 (uk) Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time